GILEAD SCIENCES, INC. Increase (Decrease) in Accounts Receivable
GILEAD SCIENCES, INC. (GILD) reported Increase (Decrease) in Accounts Receivable of $199.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-06
- GILEAD SCIENCES, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $333.00M, a 14.04% increase year-over-year.
- GILEAD SCIENCES, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$134.00M.
- GILEAD SCIENCES, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$179.00M.
- GILEAD SCIENCES, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $333.00M.
- GILEAD SCIENCES, INC. increase (decrease) in accounts receivable for fiscal 2025 was $367.00M.
- GILEAD SCIENCES, INC. increase (decrease) in accounts receivable for fiscal 2024 was -$139.00M.
- GILEAD SCIENCES, INC. increase (decrease) in accounts receivable for fiscal 2023 was -$157.00M, a 138.67% decline from fiscal 2022.
- GILEAD SCIENCES, INC. increase (decrease) in accounts receivable for fiscal 2022 was $406.00M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $333.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $199.00M 10-Q · filed 2026-08-06 | $20.00M derived: sum of 3 quarters · filed 2026-08-06 | $353.00M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$134.00M 10-Q · filed 2026-05-07 | -$313.00M derived: sum of 2 quarters · filed 2026-05-07 | $20.00M derived: sum of 3 quarters · filed 2026-05-07 | $312.00M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$179.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $154.00M derived: sum of 2 quarters · filed 2026-02-24 | $446.00M derived: sum of 3 quarters · filed 2026-08-06 | $367.00M 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | $333.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $625.00M derived: sum of 2 quarters · filed 2026-08-06 | $546.00M 10-Q · filed 2025-11-07 | $474.00M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $292.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $213.00M 10-Q · filed 2026-08-06 | $141.00M derived: sum of 3 quarters · filed 2026-08-06 | -$21.00M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$79.00M 10-Q · filed 2026-05-07 | -$151.00M derived: sum of 2 quarters · filed 2026-05-07 | -$313.00M derived: sum of 3 quarters · filed 2026-05-07 | -$284.00M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | -$72.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$234.00M derived: sum of 2 quarters · filed 2026-02-24 | -$205.00M derived: sum of 3 quarters · filed 2026-02-24 | -$139.00M 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | -$162.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$133.00M derived: sum of 2 quarters · filed 2025-11-07 | -$67.00M 10-Q · filed 2025-11-07 | -$287.00M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | $29.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $95.00M 10-Q · filed 2025-08-07 | -$125.00M derived: sum of 3 quarters · filed 2026-02-24 | $487.00M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | $66.00M 10-Q · filed 2025-05-07 | -$154.00M derived: sum of 2 quarters · filed 2026-02-24 | $458.00M derived: sum of 3 quarters · filed 2026-02-24 | $544.00M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | -$220.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $392.00M derived: sum of 2 quarters · filed 2026-02-24 | $478.00M derived: sum of 3 quarters · filed 2026-02-24 | -$157.00M 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | $612.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $698.00M derived: sum of 2 quarters · filed 2024-11-12 | $63.00M 10-Q · filed 2024-11-12 | $344.00M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-06-30 | $86.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$549.00M 10-Q · filed 2024-08-08 | -$268.00M derived: sum of 3 quarters · filed 2025-02-28 | $104.00M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-03-31 | -$635.00M 10-Q · filed 2024-05-08 | -$354.00M derived: sum of 2 quarters · filed 2025-02-28 | $18.00M derived: sum of 3 quarters · filed 2025-02-28 | $470.00M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | $281.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $653.00M derived: sum of 2 quarters · filed 2025-02-28 | $1.10B derived: sum of 3 quarters · filed 2025-02-28 | $406.00M 10-K · filed 2025-02-28 | ||||
| 2022-09-30 | $372.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $824.00M derived: sum of 2 quarters · filed 2023-11-07 | $125.00M 10-Q · filed 2023-11-07 | $84.00M derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2022-06-30 | $452.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$247.00M 10-Q · filed 2023-08-04 | -$288.00M derived: sum of 3 quarters · filed 2024-02-23 | $134.00M derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2022-03-31 | -$699.00M 10-Q · filed 2023-05-03 | -$740.00M derived: sum of 2 quarters · filed 2024-02-23 | -$318.00M derived: sum of 3 quarters · filed 2024-02-23 | -$37.00M derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2021-12-31 | -$41.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $381.00M derived: sum of 2 quarters · filed 2024-02-23 | $662.00M derived: sum of 3 quarters · filed 2024-02-23 | -$313.00M 10-K · filed 2024-02-23 | ||||
| 2021-09-30 | $422.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $703.00M derived: sum of 2 quarters · filed 2022-11-02 | -$272.00M 10-Q · filed 2022-11-02 | $565.00M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-06-30 | $281.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$694.00M 10-Q · filed 2022-08-08 | $143.00M derived: sum of 3 quarters · filed 2023-02-22 | $845.00M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-03-31 | -$975.00M 10-Q · filed 2022-05-04 | -$138.00M derived: sum of 2 quarters · filed 2023-02-22 | $564.00M derived: sum of 3 quarters · filed 2023-02-22 | -$180.00M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | $837.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $1.54B derived: sum of 2 quarters · filed 2023-02-22 | $795.00M derived: sum of 3 quarters · filed 2023-02-22 | $1.17B 10-K · filed 2023-02-22 | ||||
| 2020-09-30 | $702.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$42.00M derived: sum of 2 quarters · filed 2021-11-03 | $334.00M 10-Q · filed 2021-11-03 | $585.00M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-06-30 | -$744.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$368.00M 10-Q · filed 2021-08-05 | -$117.00M derived: sum of 3 quarters · filed 2022-02-23 | -$218.00M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-03-31 | $376.00M 10-Q · filed 2021-05-06 | $627.00M derived: sum of 2 quarters · filed 2022-02-23 | $526.00M derived: sum of 3 quarters · filed 2022-02-23 | $626.00M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2019-12-31 | $251.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $150.00M derived: sum of 2 quarters · filed 2022-02-23 | $250.00M derived: sum of 3 quarters · filed 2022-02-23 | $218.00M 10-K · filed 2022-02-23 | ||||
| 2019-09-30 | -$101.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | -$1.00M derived: sum of 2 quarters · filed 2020-11-04 | -$33.00M 10-Q · filed 2020-11-04 | -$146.00M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | $100.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $68.00M 10-Q · filed 2020-08-06 | -$45.00M derived: sum of 3 quarters · filed 2021-02-25 | -$135.00M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | -$32.00M 10-Q · filed 2020-05-06 | -$145.00M derived: sum of 2 quarters · filed 2021-02-25 | -$235.00M derived: sum of 3 quarters · filed 2021-02-25 | -$411.00M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | -$113.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$203.00M derived: sum of 2 quarters · filed 2021-02-25 | -$379.00M derived: sum of 3 quarters · filed 2021-02-25 | -$480.00M 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | -$90.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$266.00M derived: sum of 2 quarters · filed 2019-11-05 | -$367.00M 10-Q · filed 2019-11-05 | -$648.00M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-06-30 | -$176.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$277.00M 10-Q · filed 2019-08-06 | -$558.00M derived: sum of 3 quarters · filed 2020-02-25 | -$913.00M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-03-31 | -$101.00M 10-Q · filed 2019-05-08 | -$382.00M derived: sum of 2 quarters · filed 2020-02-25 | -$737.00M derived: sum of 3 quarters · filed 2020-02-25 | -$318.00M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2017-12-31 | -$281.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$636.00M derived: sum of 2 quarters · filed 2020-02-25 | -$217.00M derived: sum of 3 quarters · filed 2020-02-25 | -$754.00M 10-K · filed 2020-02-25 | ||||
| 2017-09-30 | -$355.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $64.00M derived: sum of 2 quarters · filed 2018-11-06 | -$473.00M 10-Q · filed 2018-11-06 | -$895.00M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-06-30 | $419.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | -$118.00M 10-Q · filed 2018-08-06 | -$540.00M derived: sum of 3 quarters · filed 2019-02-26 | -$1.12B derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-03-31 | -$537.00M 10-Q · filed 2018-05-09 | -$959.00M derived: sum of 2 quarters · filed 2019-02-26 | -$1.54B derived: sum of 3 quarters · filed 2019-02-26 | -$1.92B derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2016-12-31 | -$422.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$1.00B derived: sum of 2 quarters · filed 2019-02-26 | -$1.38B derived: sum of 3 quarters · filed 2019-02-26 | -$1.19B 10-K · filed 2019-02-26 | ||||
| 2016-09-30 | -$580.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$961.00M derived: sum of 2 quarters · filed 2017-11-07 | -$770.00M 10-Q · filed 2017-11-07 | -$983.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | -$381.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | -$190.00M 10-Q · filed 2017-08-07 | -$403.00M derived: sum of 3 quarters · filed 2018-02-27 | $397.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $191.00M 10-Q · filed 2017-05-10 | -$22.00M derived: sum of 2 quarters · filed 2018-02-27 | $778.00M derived: sum of 3 quarters · filed 2018-02-27 | $1.24B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | -$213.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $587.00M derived: sum of 2 quarters · filed 2018-02-27 | $1.05B derived: sum of 3 quarters · filed 2018-02-27 | $1.40B 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $800.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $1.26B derived: sum of 2 quarters · filed 2016-11-07 | $1.61B 10-Q · filed 2016-11-07 | $3.36B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | $462.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $810.00M 10-Q · filed 2016-08-05 | $2.56B derived: sum of 3 quarters · filed 2017-02-27 | $2.06B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-31 | $348.00M 10-Q · filed 2016-05-06 | $2.10B derived: sum of 2 quarters · filed 2017-02-27 | $1.59B derived: sum of 3 quarters · filed 2017-02-27 | $1.81B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-31 | $1.75B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $1.25B derived: sum of 2 quarters · filed 2017-02-27 | $1.46B derived: sum of 3 quarters · filed 2017-02-27 | $2.58B 10-K · filed 2017-02-27 | ||||
| 2014-09-30 | -$505.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | -$291.00M derived: sum of 2 quarters · filed 2015-11-04 | $827.00M 10-Q · filed 2015-11-04 | $826.97M 10-Q · filed 2014-11-05 | $915.69M derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2014-06-30 | $214.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $1.33B 10-Q · filed 2015-08-05 | $1.33B 10-Q · filed 2014-08-04 | $1.42B derived: sum of 3 quarters · filed 2016-02-24 | $1.47B derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2014-03-31 | $1.12B 10-Q · filed 2015-05-08 | $1.12B 10-Q · filed 2014-05-07 | $1.21B derived: sum of 2 quarters · filed 2016-02-24 | $1.25B derived: sum of 3 quarters · filed 2016-02-24 | $1.20B derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2013-12-31 | $88.69M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $133.73M derived: sum of 2 quarters · filed 2016-02-24 | $83.22M derived: sum of 3 quarters · filed 2016-02-24 | $315.00M 10-K · filed 2016-02-24 | $315.30M 10-K · filed 2014-02-25 | |||
| 2013-09-30 | $45.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | -$5.47M derived: sum of 2 quarters · filed 2014-11-05 | $226.31M 10-Q · filed 2014-11-05 | $189.14M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-06-30 | -$50.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $181.27M 10-Q · filed 2014-08-04 | $144.10M derived: sum of 3 quarters · filed 2015-02-25 | $163.43M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-03-31 | $231.78M 10-Q · filed 2014-05-07 | $194.61M derived: sum of 2 quarters · filed 2015-02-25 | $213.95M derived: sum of 3 quarters · filed 2015-02-25 | -$162.75M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2012-12-31 | -$37.17M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | -$17.83M derived: sum of 2 quarters · filed 2015-02-25 | -$394.53M derived: sum of 3 quarters · filed 2015-02-25 | -$198.00M 10-K · filed 2015-02-25 | -$197.99M 10-K · filed 2013-02-27 | |||
| 2012-09-30 | $19.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | -$357.36M derived: sum of 2 quarters · filed 2013-10-31 | -$160.83M 10-Q · filed 2013-10-31 | -$6.49M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-06-30 | -$376.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | -$180.17M 10-Q · filed 2013-08-01 | -$25.82M derived: sum of 3 quarters · filed 2014-02-25 | -$26.40M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-03-31 | $196.53M 10-Q · filed 2013-05-08 | $350.87M derived: sum of 2 quarters · filed 2014-02-25 | $350.30M derived: sum of 3 quarters · filed 2014-02-25 | $464.39M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | $154.34M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $153.77M derived: sum of 2 quarters · filed 2014-02-25 | $267.86M derived: sum of 3 quarters · filed 2014-02-25 | $375.74M 10-K · filed 2014-02-25 | ||||
| 2011-09-30 | -$573.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $113.52M derived: sum of 2 quarters · filed 2012-11-06 | $221.39M 10-Q · filed 2012-11-06 | $218.19M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-06-30 | $114.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-01 | $221.97M 10-Q · filed 2012-08-01 | $218.76M derived: sum of 3 quarters · filed 2013-02-27 | $328.46M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-03-31 | $107.88M 10-Q · filed 2012-05-04 | $104.67M derived: sum of 2 quarters · filed 2013-02-27 | $214.37M derived: sum of 3 quarters · filed 2013-02-27 | $292.84M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2010-12-31 | -$3.21M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $106.49M derived: sum of 2 quarters · filed 2013-02-27 | $184.96M derived: sum of 3 quarters · filed 2013-02-27 | $348.88M 10-K · filed 2013-02-27 | ||||
| 2010-09-30 | $109.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $188.17M derived: sum of 2 quarters · filed 2011-11-04 | $352.08M 10-Q · filed 2011-11-04 | $418.53M derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2010-06-30 | $78.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-05 | $242.38M 10-Q · filed 2011-08-05 | $308.83M derived: sum of 3 quarters · filed 2012-02-23 | $380.93M derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2010-03-31 | $163.91M 10-Q · filed 2011-05-09 | $230.36M derived: sum of 2 quarters · filed 2012-02-23 | $302.46M derived: sum of 3 quarters · filed 2012-02-23 | $431.30M derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2009-12-31 | $66.45M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $138.55M derived: sum of 2 quarters · filed 2012-02-23 | $267.39M derived: sum of 3 quarters · filed 2012-02-23 | $356.46M 10-K · filed 2012-02-23 | ||||
| 2009-09-30 | $72.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $200.94M derived: sum of 2 quarters · filed 2010-11-08 | $290.01M 10-Q · filed 2010-11-08 | $288.09M derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2009-06-30 | $128.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-09 | $217.91M 10-Q · filed 2010-08-09 | $215.99M derived: sum of 3 quarters · filed 2011-02-28 | $291.12M derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2009-03-31 | $89.07M 10-Q · filed 2010-05-10 | $87.15M derived: sum of 2 quarters · filed 2011-02-28 | $162.28M derived: sum of 3 quarters · filed 2011-02-28 | |||||
| 2008-12-31 | -$1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $73.21M derived: sum of 2 quarters · filed 2011-02-28 | $257.16M 10-K · filed 2011-02-28 | |||||
| 2008-09-30 | $75.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-05 | $259.09M 10-Q · filed 2009-11-05 | ||||||
| 2008-06-30 | $183.95M 10-Q · filed 2009-08-05 | |||||||
| 2007-12-31 | $138.03M 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |